Esperienze
Sono il Primario Cardiologo e Cardioncologo della Divisione di Cardiologia dell'I.N.T. Fondazione Pascale di Napoli. Sono il Presidente Nazionale dell'Associazione Italiana di Cardioncologia (AICO).
Visita Cardioncologica prima, durante e dopo la chemioterapia
Visita Cardioncologica prima, durante e dopo la chemioterapia
Aree di competenza principali:
- Cardiologia
- Medicina interna
Principali patologie trattate
- Malattie cardiovascolari
- Cancro
- Aritmia
- Ipertensione
- Insufficienza cardiaca
- +13 a11y_sr_more_diseases
Esperienze
Nicola Maurea
cardiologo, internista
Tirocini
- -
Formazione
- Università degli Studi di Napoli Federico II
- Dipartimento di Cardiologia Duke University Medical Center - Durham North Carolina, USA
- Dipartimento di Cardiologia - New England Boston, USA
- Laboratorio di Ecocardiografia - Thoraxcenter Rotterdam, Olanda
- Dipartimento di Cardiologia - Policlinico San Matteo, Pavia
Patologie trattate
- Malattie cardiovascolari
- Cancro
- Aritmia
- Ipertensione
- Insufficienza cardiaca
- Pericardite
- Miocardite
- Scompenso cardiaco
- Endocardite
- Tachicardia parossistica (TPSV)
- Cancro al seno
- Cancro alla prostata
- Linfoma
- Leucemia
- Cancro al polmone
- Cancro all'ovaio
- Cancro al colon
- Melanoma
Pubblicazioni
- Polydatin reduces cardiotoxicity of tyrosine kinase inhibitor sunitinib by decreasing pro-oxidative stress, pro-inflammatory cytokines and NLRP3 inflammasome expression. Massimiliano Berretta, Vincenzo Quagliariello, Simona Buccolo, Martina Iovine, Michelino De Laurentiis, Ernesta Cavalcanti, Raffaele Di Francia, Rosaria Taibi, Monica Montopoli, Gerardo Botti, Nicola Maurea J. Clin. Oncol. Volume 39, Issue 15_suppl, 2021.
- PCSK9 inhibitor evolocumab to increase anticancer activities and reduce cardiotoxicity during doxorubicin and trastuzumab, as sequential treatment, through MyD88/NF-kB/mTORC1 pathways. Vincenzo Quagliariello, Simona Buccolo, Martina Iovine, Andrea Paccone, Annamaria Bonelli, Ernesta Cavalcanti, Domenica Rea, Michelino De Laurentiis, Gerardo Botti, Nicola Maurea, J. Clin. Oncol. Volume 39, Issue 15_suppl, 2021.
- The SGLT-2 inhibitor dapagliflozin reduces cell death and apoptosis in cardiomyocytes exposed to trastuzumab and doxorubicin through NLRP3-mediated pathways. Nicola Maurea, Vincenzo Quagliariello, Michelino De Laurentiis, Ernesta Cavalcanti, Andrea Paccone, Simona Buccolo, Martina Iovine, Gerardo Botti; J. Clin. Oncol. Volume 39, Issue 15_suppl, 2021.
- Cytoprotective effects of spirulina extract against doxorubicin‐induced cardiotoxicity: Biochemical evidences and translational perspectives in cardio-oncology. Nicola Maurea, Vincenzo Quagliariello, Andrea Paccone, Michelino De Laurentiis, Simona Buccolo, Martina Iovine, Gerardo Botti; J. Clin. Oncol. Volume 39, Issue 15_suppl, 2021.
- OXIDIZED LOW-DENSITY LIPOPROTEIN EXACERBATES NIVOLUMAB-INDUCED CARDIOTOXICITY BY MODULATING TLR4/NF-KB AND NLRP3 PATHWAYS; Nicola Maurea, Andrea Paccone, Martina Iovine, Fabrizio Maurea, Gerardo Botti, and Vincenzo Quagliariello; J Am Coll Cardiol. 2021 May, 77 (18_Supplement_1) 3278
- CTLA-4 AND PD-1 BLOCKING AGENTS EXERTES CARDIOTOXIC, PROFIBROTIC AND PRO-INFLAMMATORY EFFECTS IN CELLULAR AND PRECLINICAL MODELS; Nicola Maurea, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Fabrizio Maurea, Gerardo Botti, Claudia De Lorenzo, and Vincenzo Quagliariello; J Am Coll Cardiol. 2021 May, 77 (18_Supplement_1) 3280
- PCSK9 INHIBITOR EVOLOCUMAB REDUCES CARDIOTOXICITY OF DOXORUBICIN AND TRASTUZUMAB SEQUENTIAL TREATMENT THROUGH MYD88/NF-KB/MTORC1 PATHWAYS; Nicola Maurea, Andrea Paccone, Martina Iovine, Gerardo Botti; Fabrizio Maurea, and Vincenzo Quagliariello; J Am Coll Cardiol. 2021 May, 77 (18_Supplement_1)3275
- Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations: from hyper-inflammation to cardiac dysfunctions V. Quagliariello, G. D’Aiuto, R.V. Iaffaioli, M. Berretta, S. Buccolo, M. Iovine, A. Paccone, F. Cerrone, S. Bonanno, G. Nunnari, N. Laganà, G. Botti, N. Maurea. Eur Rev Med Pharmacol Sci 2021; 25 (10): 3898-3907.
- Polydatin reduces cardiotoxicity and enhances the anticancer effects of Sunitinib by decreasing pro-oxidative stress, pro-inflammatory cytokines and NLRP3 inflammasome expression Vincenzo Quagliariello , Massimiliano Berretta, Simona Buccolo, Martina Iovine, Andrea Paccone, Ernesta Cavalcanti , Rosaria Taibi, Monica Montopol, Gerardo Botti, Nicola Maurea.Frontiers in oncology 2021; DOI 10.3389/fonc
- TAKOTSUBO CARDIOMYOPATHY AS EPIPHENOMENON OF CARDIOTOXICITY IN CANCER PATIENTS: A META SUMMARY OF CASE REPORTS. Carbone A, Bottino R, Russo V, D'Andrea A, Liccardo B, Maurea N, Quagliariello V, Cimmino G, Golino P. J Cardiovasc Pharmacol. 2021 Apr 5. doi: 10.1097/FJC .
- Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports.Inno A, Maurea N, Metro G, Carbone A, Russo A, Gori S. Cancer Immunol Immunother. 2021 Apr 20. doi: 021-02938-z
- Multiple Effects pf Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies. Berretta M, Quagliariello V, Maurea N, Di Francia R, Sharifi S, Facchini G, Rinaldi L, Piezzo M, Manuela C, Nunnari G, Montopoli M.Antioxidants (Basel). 2020 Nov 26;9(12):1182. doi: 10.3390/antiox9121182.
- SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients -Quagliariello V, Bonelli A, Caronna A, Conforti G, Iovine M, Carbone A, Berretta M, Botti G, Maurea N DOI: 10.3390/canc1r112113316
- NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells Quagliariello V, De Laurentiis M, Cocco S, Rea G, Bonelli A, Caronna A, Lombari MC, Conforti G, Berretta M, Botti G, Maurea N Int J Mol Sci. 2020
- Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models- Quagliariello V, Passariello M, Rea D, Barbieri A, Iovine M, Bonelli A, Caronna A, Botti G, De Lorenzo C, Maurea N J Pers Med 2020 Oct 19;10(4):E179.
- SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications? Quagliariello V, Bonelli A, Caronna A, Lombari MC, Conforti G, Libutti M, Iaffaioli RV, Berretta M, Botti G, Maurea N. - Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9169-9171. doi: 10.26355/1urr1v_202009_22867
- Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab- Quagliariello V, Vecchione R, De Capua A, Lagreca E, Iaffaioli RV, Botti G, Netti PA, Maurea N. Int J Nanomedicine. 2020 Jul 9;15:4859-4876
- Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy - Canale ML, Camerini A, Casolo G, Lilli A, Bisceglia I, Parrini I, Lestuzzi C, Del Meglio J, Puccetti C, Camerini L, Amoroso D, Maurea N Adv Ther. 2020 Jul;37(7):3178-3184
- Resveratrol in Cancer Patients: From Bench to Bedside. - Berretta M, Bignucolo A, Di Francia R, Comello F, Facchini G, Ceccarelli M, Iaffaioli RV, Quagliariello V, Maurea N Int J Mol Sci. 2020 Apr 22;21(8):2945.
- Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab Quagliariello V, Passariello M, Coppola C, Rea D, Barbieri A, Scherillo M, Monti MG, Iaffaioli RV, De Laurentiis M, Ascierto PA, Botti G, De Lorenzo C, Maurea N Int J Cardiol. 2019 Oct 1;292:171-179
- Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells Barbarisi M, Barbarisi A, De Sena G, Armenia E, Aurilio C, Libutti M, Iaffaioli RV, Botti G, Maurea N, Quagliariello V Phytother Res. 2019 Jun;33(6):1670-1682
- Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts Quagliariello V, Coppola C, Mita DG, Piscopo G, Iaffaioli RV, Botti G, Maurea N. Environ Toxicol Pharmacol. 2019 Jul;69:1-8.
- Edoxaban in patients with atrial fibrillation and cancer - Maurea N, Riva L G Ital Cardiol (Rome). 2018
- Venous thromboembolism and atrial fibrillation in patients with cancer - Maurea N, Riva L. G Ital Cardiol (Rome). 2018
- Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity Quagliariello V, Vecchione R, Coppola C, Di Cicco C, De Capua A, Piscopo G, Paciello R, Narciso V, Formisano C, Taglialatela-Scafati O, Iaffaioli RV, Botti G, Netti PA, Maurea N Nutrients. 2018 Sep 14;10(9):1304.
- Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N Onco Targets Ther. 2018
- Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production Riccio G, Antonucci S, Coppola C, D'Avino C, Piscopo G, Fiore D, Maurea C, Russo M, Rea D, Arra C, Condorelli G, Di Lisa F, Tocchetti CG, De Lorenzo C, Maurea N. Front Physiol. 2018 Feb 6;9:38
- Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs Coppola C, Rienzo A, Piscopo G, Barbieri A, Arra C, Maurea N Cancer Treat Rev. 2018 Feb;63:135-143
- Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis? De Vecchis R, Noutsias M, Ariano C, Cesaro A, Cioppa C, Giasi A, Maurea N J Clin Med Res. 2017 Apr;9(4):266-272
Premi e riconoscimenti
- -
Prestazioni e prezzi
-
Consulenza online
-
-
Visita cardiologica
-
Indirizzi (2)
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
Napoli 80132
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
Recensioni in arrivo
Scrivi la prima recensione
Hai avuto una visita con Prof. Nicola Maurea? Condividi quello che pensi. Grazie alla tua esperienza gli altri pazienti potranno scegliere il miglior dottore per loro.
Aggiungi una recensione